Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1983;5:653-662

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okuno, T.
Right arrow Articles by Oparil, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okuno, T.
Right arrow Articles by Oparil, S.

Hypertension, Vol 5, 653-662, Copyright © 1983 by American Heart Association


ARTICLES

Attenuation of the development of spontaneous hypertension in rats by chronic central administration of captopril

T Okuno, S Nagahama, MD Lindheimer and S Oparil

Captopril infused into the lateral ventricle (ICV) of adult spontaneously hypertensive rats (SHR) decreases blood pressure. The current study was designed to explore the effects of brain converting- enzyme inhibition in young animals before the development of established hypertension and to characterize changes induced by captopril in a variety of pressor systems that might be responsible for the development of hypertension in this strain. Captopril (1.25 micrograms/0.5 microliter/hr) was infused into male SHR starting at 7 weeks of age. Four weeks later systolic blood pressure was only 157 +/- 3.3 compared to 181 +/- 3.9 mm Hg in vehicle-infused controls, and the pressor effect of ICV-injected angiotensin I was attenuated by 50%. When the same dose of captopril was infused intravenously, hypertension progressed as in vehicle-treated rats. Serum angiotensin-converting enzyme activity (SACE) and plasma arginine vasopressin (AVP) concentration were significantly higher (p less than 0.001 and 0.05, respectively), in the ICV captopril group than in the ICV vehicle group, while plasma aldosterone concentration and renin activity, fluid intake, urine volume, and urinary sodium excretion were similar in the two groups. Peripheral sympathetic nervous system activity assessed in the resting state was not altered by captopril treatment. In addition, AVP content of the telencephalon, diencephalon, mesencephalon, and pons medulla were not altered by ICV captopril. Renin activity was elevated in the telencephalon of ICV captopril-treated animals but unaltered in the other brain regions examined. These data demonstrate that ICV administration of captopril attenuates the development of hypertension in young SHR by mechanisms apparently independent of altered fluid and sodium balance and the sympathoadrenal system. The effect on blood pressure occurs in the absence of changes in renin activity or AVP content of plasma or those brain regions most often associated with blood pressure control.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Sherrod, X. Liu, X. Zhang, and C. D. Sigmund
Nuclear localization of angiotensinogen in astrocytes
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2005; 288(2): R539 - R546.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. L. Lavoie, M. D. Cassell, K. W. Gross, and C. D. Sigmund
Adjacent Expression of Renin and Angiotensinogen in the Rostral Ventrolateral Medulla Using a Dual-Reporter Transgenic Model
Hypertension, May 1, 2004; 43(5): 1116 - 1119.
[Abstract] [Full Text] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
A. M Allen
Blockade of angiotensin AT1-receptors in the rostral ventrolateral medulla of spontaneously hypertensive rats reduces blood pressure and sympathetic nerve discharge
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2001; 2(1_suppl): S120 - S124.
[Abstract] [PDF]


Home page
Circ. Res.Home page
R. L. Davisson, G. Yang, T. G. Beltz, M. D. Cassell, A. K. Johnson, and C. D. Sigmund
The Brain Renin-Angiotensin System Contributes to the Hypertension in Mice Containing Both the Human Renin and Human Angiotensinogen Transgenes
Circ. Res., November 16, 1998; 83(10): 1047 - 1058.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. R. Britto, R. A. S. Santos, C. R. Fagundes-Moura, M. C. Khosla, and M. J. Campagnole-Santos
Role of Angiotensin-(1-7) in the Modulation of the Baroreflex in Renovascular Hypertensive Rats
Hypertension, September 1, 1997; 30(3): 549 - 556.
[Abstract] [Full Text]


Home page
HypertensionHome page
B. S. Huang and F. H.H. Leenen
Brain "Ouabain" and Angiotensin II in Salt-Sensitive Hypertension in Spontaneously Hypertensive Rats
Hypertension, December 1, 1996; 28(6): 1005 - 1012.
[Abstract] [Full Text]


Home page
HypertensionHome page
D. R. Oliveira, R. A.S. Santos, G. F.P. Santos, M. C. Khosla, and M. J. Campagnole-Santos
Changes in the Baroreflex Control of Heart Rate Produced by Central Infusion of Selective Angiotensin Antagonists in Hypertensive Rats
Hypertension, June 1, 1996; 27(6): 1284 - 1290.
[Abstract] [Full Text]